NASDAQ:TTPH
Delisted

Tetraphase Pharmaceuticals Stock Forecast

$2.20
+0 (+0%)
At Close: Sep 04, 2020
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Friday for Tetraphase Pharmaceuticals stock after losing 0%
(Updated on Sep 04, 2020)

Hold candidate since Jul 30, 2020 PDF

No changes to the price of Tetraphase Pharmaceuticals stock on the last trading day (Friday, 4th Sep 2020). During the last trading day the stock fluctuated 0% from a day low at $2.20 to a day high of $2.20. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.59% during the next 3 months and, with a 90% probability hold a price between $1.59 and $2.12 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TTPH Signals & Forecast

There are mixed signals in the stock today. The Tetraphase Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.20 and $2.23. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Tuesday, July 28, 2020, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Tetraphase Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $2.07 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 28 days ago.)

Trading Expectations (TTPH) For The Upcoming Trading Day Of Tuesday 8th

For the upcoming trading day on Tuesday, 8th we expect Tetraphase Pharmaceuticals to open at $2.20, and during the day (based on 14 day Average True Range), to move between $2.18 and $2.22, which gives a possible trading interval of +/-$0.0197 (+/-0.89%) up or down from last closing price. If Tetraphase Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 1.79% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.35, some $0.150 (6.82%) from the current price of $2.20, our system finds the risk reward not very attractive.

Is Tetraphase Pharmaceuticals stock A Buy?

Tetraphase Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Tetraphase Pharmaceuticals of Tuesday, September 8, 2020

Fair opening price September 8, 2020 Current price
$2.20 ( 0%) $2.20

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TTPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.20 .
R2 2.20 .
R1 2.20 .
Current price: 2.20
Support S1 2.20 .
S2 2.20 .
S3 2.20 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.70 22.73 %
R2 2.45 11.36 %
R1 2.35 6.82 %
Current price 2.20
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Tetraphase Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Tetraphase Pharmaceuticals is TTPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tetraphase Pharmaceuticals Stock?
Tetraphase Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Tetraphase Pharmaceuticals Stock?
Tetraphase Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tetraphase Pharmaceuticals Stock.

What's the current price of Tetraphase Pharmaceuticals Stock?
As of the end of day on the 2020-09-04, the price of an Tetraphase Pharmaceuticals (TTPH) share was $2.20.

What is the 52-week high and low for Tetraphase Pharmaceuticals Stock?
The 52-week high for Tetraphase Pharmaceuticals Stock is $6.17 and the 52-week low is $0.235.
Click to get the best stock tips daily for free!

About Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections. Its lead product candidate includes eravacycline, an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative infections. The company has complet... TTPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT